About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalTaiwan
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
184
By Phase
NA: 1PHASE3: 1
By Status
COMPLETED: 1SUSPENDED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06328166Collaborator
The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome
NACompleted
24 participants
Started: Mar 22, 2024 · Completed: May 30, 2025
NCT03229031Lead Sponsor
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury
PHASE3Suspended
160 participants
Started: Mar 7, 2018 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...